341 related articles for article (PubMed ID: 34572024)
1. Human Neural Stem Cells for Cell-Based Medicinal Products.
Fernandez-Muñoz B; Garcia-Delgado AB; Arribas-Arribas B; Sanchez-Pernaute R
Cells; 2021 Sep; 10(9):. PubMed ID: 34572024
[TBL] [Abstract][Full Text] [Related]
2. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine.
Zhang Y; Hu W; Ma K; Zhang C; Fu X
Stem Cell Rev Rep; 2019 Oct; 15(5):680-689. PubMed ID: 31197578
[TBL] [Abstract][Full Text] [Related]
4. Preparation of Neural Stem Cells and Progenitors: Neuronal Production and Grafting Applications.
Zholudeva LV; Jin Y; Qiang L; Lane MA; Fischer I
Methods Mol Biol; 2021; 2311():73-108. PubMed ID: 34033079
[TBL] [Abstract][Full Text] [Related]
5. [Stem Cells in the Brain of Mammals and Human: Fundamental and Applied Aspects].
Aleksandrova MA; Marey MV
Zh Vyssh Nerv Deiat Im I P Pavlova; 2015; 65(3):271-305. PubMed ID: 26281227
[TBL] [Abstract][Full Text] [Related]
6. Sources of stem cells for regenerative medicine.
Hipp J; Atala A
Stem Cell Rev; 2008; 4(1):3-11. PubMed ID: 18286392
[TBL] [Abstract][Full Text] [Related]
7. Current progress in the derivation and therapeutic application of neural stem cells.
Tang Y; Yu P; Cheng L
Cell Death Dis; 2017 Oct; 8(10):e3108. PubMed ID: 29022921
[TBL] [Abstract][Full Text] [Related]
8. Preparation of neural stem cells and progenitors: neuronal production and grafting applications.
Bonner JF; Haas CJ; Fischer I
Methods Mol Biol; 2013; 1078():65-88. PubMed ID: 23975822
[TBL] [Abstract][Full Text] [Related]
9. Microfabric Vessels for Embryoid Body Formation and Rapid Differentiation of Pluripotent Stem Cells.
Sato H; Idiris A; Miwa T; Kumagai H
Sci Rep; 2016 Aug; 6():31063. PubMed ID: 27507707
[TBL] [Abstract][Full Text] [Related]
10. Human Pluripotent Stem Cells for Spinal Cord Injury.
Farzaneh M; Anbiyaiee A; Khoshnam SE
Curr Stem Cell Res Ther; 2020; 15(2):135-143. PubMed ID: 31656156
[TBL] [Abstract][Full Text] [Related]
11. Pluripotent stem cells - a review of the current status in neural regeneration.
Paspala SA; Murthy TV; Mahaboob VS; Habeeb MA
Neurol India; 2011; 59(4):558-65. PubMed ID: 21891934
[TBL] [Abstract][Full Text] [Related]
12. Novel paths towards neural cellular products for neurological disorders.
Daadi MM
Regen Med; 2011 Nov; 6(6 Suppl):25-30. PubMed ID: 21999259
[TBL] [Abstract][Full Text] [Related]
13. Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges.
Ford E; Pearlman J; Ruan T; Manion J; Waller M; Neely GG; Caron L
Cells; 2020 Nov; 9(11):. PubMed ID: 33233861
[TBL] [Abstract][Full Text] [Related]
14. Generation of in vivo neural stem cells using partially reprogrammed cells defective in in vitro differentiation potential.
Kim JS; Hong YJ; Choi HW; Song H; Byun SJ; Do JT
Oncotarget; 2017 Mar; 8(10):16456-16462. PubMed ID: 28147316
[TBL] [Abstract][Full Text] [Related]
15. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
[TBL] [Abstract][Full Text] [Related]
16. Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications.
Moraghebi R; Kirkeby A; Chaves P; Rönn RE; Sitnicka E; Parmar M; Larsson M; Herbst A; Woods NB
Stem Cell Res Ther; 2017 Aug; 8(1):190. PubMed ID: 28841906
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
de Lázaro I; Yilmazer A; Kostarelos K
J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
[TBL] [Abstract][Full Text] [Related]
18. Characterization of stem cells from human ovarian follicular fluid; a potential source of autologous stem cell for cell-based therapy.
Rungsiwiwut R; Numchaisrika P; Thuwanut P; Pruksananonda K
Hum Cell; 2021 Mar; 34(2):300-309. PubMed ID: 33543452
[TBL] [Abstract][Full Text] [Related]
19. Turning straw into gold: directing cell fate for regenerative medicine.
Cohen DE; Melton D
Nat Rev Genet; 2011 Apr; 12(4):243-52. PubMed ID: 21386864
[TBL] [Abstract][Full Text] [Related]
20. Neural stem cell therapy for stroke: A multimechanistic approach to restoring neurological function.
Baker EW; Kinder HA; West FD
Brain Behav; 2019 Mar; 9(3):e01214. PubMed ID: 30747485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
